Holen Sie sich die Stockscreener-App
1.19
4.80%
-0.06
Schlusskurs vom Vortag:
$1.25
Offen:
$1.25
24-Stunden-Volumen:
223.52K
Relative Volume:
0.36
Marktkapitalisierung:
$31.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-10.21M
KGV:
-2.037
EPS:
-0.5842
Netto-Cashflow:
-
1W Leistung:
-4.80%
1M Leistung:
-12.50%
6M Leistung:
+20.36%
1J Leistung:
-2.46%
1-Tages-Spanne:
$1.17
$1.27
1-Wochen-Bereich:
$1.12
$1.27
52-Wochen-Spanne:
$0.80
$2.60
Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
Firmenname
Neurosense Therapeutics Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie NRSN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRSN
Neurosense Therapeutics Ltd
|
1.19 | 31.30M | 0 | -10.21M | 0 | -0.5842 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Neurosense Therapeutics Ltd Aktie (NRSN) Neueste Nachrichten
How NeuroSense Therapeutics Ltd. Equity Warrant stock performs in stagflationWeekly Stock Report & Free High Return Stock Watch Alerts - newser.com
What institutional flow reveals about NeuroSense Therapeutics Ltd.Quarterly Investment Review & Weekly Breakout Stock Alerts - newser.com
Is it too late to sell NeuroSense Therapeutics Ltd.Trade Signal Summary & Daily Technical Forecast Reports - newser.com
Using R and stats models for NeuroSense Therapeutics Ltd. Equity Warrant forecasting2025 Top Gainers & Community Verified Swing Trade Signals - newser.com
Historical volatility pattern of NeuroSense Therapeutics Ltd. Equity Warrant visualizedMarket Rally & Advanced Technical Signal Analysis - newser.com
Can a trend reversal in NeuroSense Therapeutics Ltd. lead to recoveryTrade Exit Report & Weekly Stock Breakout Alerts - newser.com
How sentiment analysis helps forecast NeuroSense Therapeutics Ltd. Equity WarrantSwing Trade & Reliable Intraday Trade Plans - newser.com
Will NeuroSense Therapeutics Ltd. stock return to pre crisis levelsJuly 2025 Volume & Daily Stock Trend Watchlist - newser.com
Using economic indicators to assess NeuroSense Therapeutics Ltd. Equity Warrant potentialWeekly Trade Review & Daily Chart Pattern Signal Reports - newser.com
Using data filters to optimize entry into NeuroSense Therapeutics Ltd.Weekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Can NeuroSense Therapeutics Ltd. Equity Warrant rally from current levelsTrade Analysis Summary & Safe Entry Point Identification - newser.com
Real time scanner hits for NeuroSense Therapeutics Ltd. explained2025 Risk Factors & Long-Term Safe Investment Plans - newser.com
Will NeuroSense Therapeutics Ltd. (H1Z) stock draw ESG focused fundsInsider Selling & Free Daily Entry Point Trade Alerts - newser.com
Backtesting results for NeuroSense Therapeutics Ltd. trading strategiesTrade Signal Summary & AI Forecasted Entry/Exit Points - newser.com
NeuroSense Therapeutics Ltd. stock momentum explainedInsider Selling & Stock Portfolio Risk Management - newser.com
NeuroSense Therapeutics (NASDAQ:NRSN) Shares Down 1.7% – Time to Sell? - Defense World
NeuroSense: PrimeC Produces Statistically Significant Reductions in Alzheimer's Disease Biomarkers - Sahm
Why NeuroSense Therapeutics Ltd. (H1Z) stock attracts wealthy investorsJuly 2025 Volume & Consistent Growth Equity Picks - newser.com
NeuroSense Announces Promising Alzheimer’s Biomarker Reductions with PrimeC - TipRanks
Neurosense Therapeutics LtdPrimeC produces statistically significant reductions in Alzheimer's disease biomarkers - MarketScreener
Volume spikes in NeuroSense Therapeutics Ltd. stock – what they meanPortfolio Risk Summary & Risk Controlled Daily Trade Plans - newser.com
Heatmap analysis for NeuroSense Therapeutics Ltd. Equity Warrant and competitorsPrice Action & Daily Oversold Stock Bounce Ideas - newser.com
Will NeuroSense Therapeutics Ltd. stock continue dividend increasesJuly 2025 Closing Moves & Safe Capital Growth Stock Tips - newser.com
Why NeuroSense Therapeutics Ltd. stock is rated strong buyMarket Activity Report & Daily Profit Focused Screening - newser.com
Is NeuroSense Therapeutics Ltd. (H1Z) stock undervalued after correctionInsider Selling & High Win Rate Trade Tips - newser.com
Published on: 2025-10-05 05:10:08 - newser.com
Will NeuroSense Therapeutics Ltd. Equity Warrant stock maintain dividend yieldJuly 2025 Review & Daily Chart Pattern Signals - newser.com
Leading vs lagging indicators on NeuroSense Therapeutics Ltd. Equity Warrant performanceEarnings Risk Report & High Yield Stock Recommendations - newser.com
Published on: 2025-10-05 02:56:57 - newser.com
NeuroSense Reports Positive Initial Results for Alzheimer’s Drug Candidate - MSN
Why hedge funds are buying NeuroSense Therapeutics Ltd. Equity Warrant stock2025 Historical Comparison & Momentum Based Trading Signals - newser.com
Is NeuroSense Therapeutics Ltd. Equity Warrant stock undervalued vs historical averagesTrade Analysis Summary & Safe Capital Growth Tips - newser.com
Published on: 2025-10-03 05:13:43 - newser.com
Why NeuroSense Therapeutics Ltd. (H1Z) stock is a must watch tickerJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - newser.com
Published on: 2025-10-02 23:30:57 - newser.com
Finanzdaten der Neurosense Therapeutics Ltd-Aktie (NRSN)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):